Abiopharma

🔍 Blue & Silver Ventures, Ltd. (Executive)

Company: GameSquare Holdings, Inc. (GAME)

Report Date: 2026-04-22

Detailed Transactions and Holdings:

• Acquired 809,109 shares of Common Stock at $0.58 per share (Direct)
  Date: 2026-04-22 | Code: P | equity_swap_involved: 0 | shares_owned_after: 2,436,481.00 | transaction_form_type: 4 | Footnotes: F3, F1
• Acquired 922,890 shares of Common Stock at $0.6 per share (Direct)
  Date: 2026-04-23 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,359,371.00 | transaction_form_type: 4 | Footnotes: F4, F1
• Acquired 417,813 shares of Common Stock at $0.6 per share (Direct)
  Date: 2026-04-24 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,777,184.00 | transaction_form_type: 4 | Footnotes: F5, F1
• Acquired 84,552 shares of Common Stock at $0.6 per share (Direct)
  Date: 2026-04-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,861,736.00 | transaction_form_type: 4 | Footnotes: F6, F1

Footnotes:

• F1: Thomas L. Walker, who is a director of the issuer, is the treasurer for the reporting person and serves on the issuer's board of directors as the reporting person's representative. In light of Mr. Walker's relationship with the reporting person, the reporting person may be deemed a "director by deputization" of the issuer for purposes of Section 16 of the Securities Exchange Act of 1934. This filing is therefore being made out of an abundance of caution, without taking any position as to whether the reporting person is in fact a director by deputization. Mr. Walker disclaims beneficial ownership of any securities of the issuer held by the reporting person, except to the extent of his pecuniary interest therein, if any.
• F2: The reporting person's beneficial ownership reflected herein includes 4,131 shares of common stock issued to the reporting person, which were omitted from prior Forms 4.
• F3: Represents the weighted average sale price of Common Stock purchased in a series of open market transactions on the transaction date at prices ranging from $0.4697 to $0.60 per share.
• F4: Represents the weighted average sale price of Common Stock purchased in a series of open market transactions on the transaction date at prices ranging from $0.580 to $0.60 per share.
• F5: Represents the weighted average sale price of Common Stock purchased in a series of open market transactions on the transaction date at prices ranging from $0.5902 to $0.60 per share.
• F6: Represents the weighted average sale price of Common Stock purchased in a series of open market transactions on the transaction date at prices ranging from $0.5970 to $0.60 per share.
• F7: The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.